Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8655 |
High Similarity |
NPD228 |
Approved |
0.8512 |
High Similarity |
NPD5283 |
Phase 1 |
0.8397 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8359 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8244 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8209 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8209 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8168 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.8099 |
Intermediate Similarity |
NPD2684 |
Approved |
0.8074 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD5846 |
Approved |
0.8045 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7985 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7984 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7941 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7941 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7939 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7937 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7926 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7795 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7794 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7704 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7681 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7655 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7642 |
Intermediate Similarity |
NPD968 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7589 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7552 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7537 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7537 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7519 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5735 |
Approved |
0.75 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7481 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7481 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7479 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7479 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7463 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7445 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD290 |
Approved |
0.7438 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7434 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7424 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD5109 |
Approved |
0.741 |
Intermediate Similarity |
NPD3145 |
Approved |
0.741 |
Intermediate Similarity |
NPD3144 |
Approved |
0.741 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7403 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7395 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7395 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7395 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7388 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7379 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7376 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7357 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7338 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7317 |
Intermediate Similarity |
NPD291 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD821 |
Approved |
0.7286 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD4749 |
Approved |
0.726 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7256 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7255 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7248 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7234 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7226 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7222 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7206 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD6353 |
Approved |
0.72 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7185 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7185 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6543 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6540 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6542 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6539 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7133 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7132 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7123 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD7265 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7111 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7111 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7105 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6538 |
Approved |
0.7101 |
Intermediate Similarity |
NPD6541 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD6179 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1512 |
Approved |
0.708 |
Intermediate Similarity |
NPD1608 |
Approved |
0.708 |
Intermediate Similarity |
NPD2232 |
Approved |
0.708 |
Intermediate Similarity |
NPD2233 |
Approved |
0.708 |
Intermediate Similarity |
NPD2230 |
Approved |
0.708 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6032 |
Approved |
0.705 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7044 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7032 |
Intermediate Similarity |
NPD5722 |
Discontinued |
0.7031 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7029 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7019 |
Intermediate Similarity |
NPD27 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7007 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7007 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7018 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD7054 |
Approved |
0.6994 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD3530 |
Approved |
0.6993 |
Remote Similarity |
NPD3532 |
Approved |
0.6993 |
Remote Similarity |
NPD3531 |
Approved |
0.6993 |
Remote Similarity |
NPD7477 |
Discontinued |
0.6992
|
Remote Similarity |
NPD2557 |
Approved |